✦ LIBER ✦

Gangliosides as antigenic targets for active and passive immunization of patients with small cell lung cancer (SCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of paclitaxel as first li

✍ Langley, R.E.; Woll, P.J.; Davidson, N.; Libretti, V.; Smyth, J.F.; Schipper, R; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 212 KB

The role of mediastinoscopy (M) in the p

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 93 KB

A phase II study of paclitaxel (P) and c

✍ Agelaki, S.; Agelidou, M.; Blazogiannakis, G.; Tsiafaki, X.; Palamidas, Th.; Kou 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 325 KB

P-560 Phase I-II study of amrubicin and

✍ Matsui, Kaoru; Ohe, Yuichiro; Negoro, Shunichi; Nakagawa, Kazuhiko; Sugiura, Tak 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Phase II trial with ISIS 5132 in patient

✍ B Coudert; A Anthoney; W Fiedler; J.P Droz; V Dieras; M Borner; J.F Smyth; R Mor 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 93 KB

The ratio between pretreatment γ-enolase

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 135 KB